SAMA Resource Group for Women and HealthHingorani, ShaileyGulati, Rishabh2011-07-072011-07-072009http://hdl.handle.net/10625/46457Low costs, easy access to otherwise highly regulated technologies and easy availability of surrogate mothers and gamete donors have made India a favoured destination for these procedures posing ethical, legal and social dilemmas, including the increasing commodification and commercialization of women's reproductive tissues. This policy brief highlights concerns with regard to the Draft Assisted Reproductive Technology (Regulation) Bill, to engage parliamentarians and policy makers towards a more effective and comprehensive legislation. There should be clear articulation of health risks borne by the users, especially women and surrogate mothers, and the children born through ARTs.Text1 digital file (4 p.)enREPRODUCTIVE HEALTHREPRODUCTIVE RIGHTSWOMEN'S HEALTHWOMEN'S RIGHTSASSISTED REPRODUCTIVE TECHNOLOGIESSURROGATE MOTHERSSURROGACYFEMINISMINDIAPolicy Brief